July 17, 2009 – AGA Medical Corp. received European CE mark approval for its AMPLATZER vascular plug, AVP 4, which is indicated for arterial and venous embolizations in the peripheral vasculature.
The device uses AMPLATZER’s proven mesh-braided nitinol technology and may eliminate the need for a catheter exchange, giving physicians a more efficient procedure, the company said. AGA Medical will begin marketing the AVP 4 in Europe immediately.
With its low profile, the AVP 4 allows delivery through a standard 0.038 diagnostic catheter. Physicians use one AVP 4 instead of multiple coil implants. A single device solution for peripheral embolization, the AVP 4 extends the AMPLATZER vascular plug family to smaller and often more distal vasculature. The device’s multilayered, double-lobed design provides rapid embolization. The flexible mesh and floppy distal section of the delivery wire facilitate easy tracking through torturous anatomy as well. AGA offers the AVP 4 in diameters ranging from 4 mm to 8 mm.
For more information: www.amplatzer.com
August 26, 2026 
